HOME >> MEDICINE >> NEWS
A drug's brand name skews patient treatment choices

The brand name of a drug can strongly influence treatment decisions by patients, according to a randomized trial of decision aids by researchers from McMaster University.

The unexpected finding regarding the strong influence that drug names have on treatment choices emerged from a study undertaken by Dr. Anne Holbrook and McMaster colleagues who wanted to see if certain features of a decision aid i.e., format and graphic presentation of data on benefits and harms of treatment options make a difference. They designed a decision aid for anticoagulant drug therapy for atrial fibrillation in 3 formats (decision board, decision booklet with audiotape, or interactive computer program) with 2 types of data presentation (pie graph or pictogram). The treatment options were identified initially as "treatment A" (warfarin), "treatment B" (acetylsalicylic acid) and "treatment C" (no treatment). The authors found that the participants comprehension of the condition and treatment options improved significantly with the decision aid, regardless of the format or graphic presentation of data. Virtually all (96%) of the participants felt that the decision aid helped them make their treatment choice.

But unexpectedly, they also discovered that after participants were shown the true treatment names, 36% changed their initial choice (including 46% of those who initially chose warfarin and 78% of those who initially chose no treatment), even though the risks and benefits of each treatment were clearly laid out in the decision aid.

In a related commentary, Dr. Annette O'Connor notes that many common medical decisions exist in a "grey zone," where the best choice differs depending on how patients weigh the benefits and risks of each treatment option. She discusses how patient decision aids differ from educational aids and how they help patients and express their personal values.


'"/>

Contact: Dr. Anne Holbrook
905-525-9140 x22169
Canadian Medical Association Journal
21-May-2007


Page: 1

Related medicine news :

1. Chemical maps hint at drugs effects on schizophrenia
2. Study to test drugs potential to preserve insulin production in newly diagnosed type 1 diabetics
3. Anti-inflammatory drugs potentially deadly side effect found to be rare
4. Trial demonstrates new drugs effectiveness against psoriasis
5. Young childrens taste preferences may be influenced by fast-food branding
6. MRI shows brains respond better to name brands
7. Mega-brands have mega influence on dietary behavior
8. Alcohol-branded merchandise associated with early teen drinking
9. Brain-scanning technology reveals how we process brands and products
10. Where your brain wires itself to like (name your favorite brand)
11. Health benefits of a Christmas brandy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... , ... April 28, 2017 , ... ... Replace tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent ... rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... pilot study of ActiGraph’s CentrePoint Data Hub in a sample of ... of clinical-grade wearable activity and sleep monitoring solutions for the global scientific community. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor ... leant his presence to an educational purpose as the host of the “Informed” series. ... cancer. In a recent episode, the series focuses on thyroid cancer. , Although thyroid ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying to meet talent shortages ... outdated healthcare executive resume. , “If you’re a healthcare executive open to new opportunities ... if it’s as ready as you are for a new job search. I’ve heard ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 2017 Halo Labs announces the launch of ... system called the Horizon at PEGS 2017 in ... system analyzes sub visible particulate matter in biopharmaceutical samples ... as early as candidate selection and pre-formulation. ... research organization Elion Labs for system validation. ...
(Date:4/20/2017)... , April 20, 2017 Research ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities ... to their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming ... provides an in-depth assessment of the current trends in ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology:
Cached News: